View all news

    Janssen to Discontinue Pimodivir Influenza Development Program

    09/02/2020
    Download(opens in new window)PDF 116 KB

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com